Jerusalem Finance And Issuances In 2025: Bigger Balance Sheet, Same Single-Name Credit

Company Overview

At first glance, Jerusalem Issues looks like a company with a NIS 3.03 billion balance sheet, NIS 48.2 million of equity, and NIS 7.5 million of net profit. That is only a partial read. This is not a bank, not an independent lender, and not an operating business trying to build a meaningful margin for itself. It is Bank Jerusalem's debt-raising arm: the company issues bonds and subordinated instruments, places the proceeds at Bank Jerusalem on equal or better terms, and keeps only a very thin residual spread.

What is actually working now is the funding conduit itself. In 2025 the company expanded Series 19 in January, launched Series 20 in November, grew the balance sheet by 4.3%, and kept senior-debt ratings of Aa2.il at Midroog and ilAA- at Maalot. What is still not clean matters just as much: the issuer's own economics barely improved, the core spread weakened, and almost all material risk still sits with Bank Jerusalem.

That is also the right actionability filter. The company is listed as a bond-only vehicle, with no tradable common equity. So this is not a question of equity upside or standalone operating leverage. The relevant question is whether Bank Jerusalem can keep using this issuer as a stable capital-markets funding wrapper, and at what price. Read it like a normal operating company and the story disappears. Read it only through headline balance-sheet growth and you miss a different point: this is still almost a single-name credit exposure to Bank Jerusalem.

The right framing for 2026 looks like a funding bridge year, not a breakout year. Series 20 already increased scale, but it did not turn the company into a better business. For the read to improve, the next debt cycle would need to come at no worse pricing, the core spread would need to stabilize, and Bank Jerusalem credit quality would need to remain strong enough to hold the entire structure together.

Quick orientation:

What is misleading here is that the balance sheet expanded, but the risk did not diversify. It did the opposite. Even in 2025 almost the entire asset base remained a deposit at Bank Jerusalem, so the thesis still depends on one question: whether the bank can keep paying holders, maintain stable ratings, and continue using the capital market at a reasonable price.

Events And Triggers

The first trigger: in January 2025 the company expanded Series 19 by NIS 232.81 million par value, for roughly NIS 248.2 million of gross proceeds. That shows market access was already open early in the year, before the new November issue.

The second trigger: in November 2025 a full issuance cycle was built around Series 20. The company had published a shelf prospectus in October, received ilAA- from Maalot and Aa2.il from Midroog in November for up to NIS 350 million par value, and on November 27 the rated amount was raised to up to NIS 400 million par value. On November 30 the issue was completed at NIS 388.217 million par value, with a 2.57% annual coupon.

The third trigger: the demand profile matters as much as the size. The shelf-offer report allowed up to NIS 453.287 million par value to be offered, and the company also said that if demand exceeded NIS 400 million par value it would not issue the excess amount. In practice, 50 orders were received for only 388.217 million units, of which 387.958 million came from qualified investors and only 0.259 million from the public. Market access clearly existed, but this was not an issue that spilled above the practical ceiling or cleared with visibly stronger pricing tension.

The fourth trigger: pricing itself was sharp. The final coupon was set at 2.57%, exactly the maximum annual coupon allowed in the offer. That is not a distress signal. But it is also not a signal of strong pricing power. It says the company raised the money, but not on terms that suggest exceptional excess demand.

The fifth trigger: in April 2025 the company reported that Bank Jerusalem had purchased NIS 100 million par value of Series 18 in an off-exchange transaction. By December 31, 2025 the bank held NIS 210.4 million par value of Series 18, equal to 32.68% of that series, and NIS 242.8 million of the company's bonds in total. That does not cancel the debt, but it does mean part of the stack is already sitting back with the parent.

The sixth trigger: on December 4, 2025 Eli Tatro was appointed CEO, while Moshe Omer ceased serving as acting CEO and remained chairman. That is not a thesis item on its own, but it reinforces the point that this is a tightly parent-linked funding vehicle rather than a business with wide operational autonomy.

The meaning of 2025 is therefore not "business expansion." It was a balance-sheet management year. The company added scale, opened a new series, managed the existing stack, and continued serving Bank Jerusalem as a funding arm. That is useful, but it is not the same thing as a stronger standalone economic profile.

Efficiency, Profitability And Competition

The core spread weakened more than the bottom line suggests

The most interesting number in the report is not net profit. It is net interest and linkage income. In 2025 that line fell to NIS 7.371 million from NIS 11.187 million in 2024, a decline of about 34%. At the same time, net finance income slipped only to NIS 10.925 million from NIS 11.299 million, and net profit actually edged up to NIS 7.455 million.

That gap matters a lot. It means the contractual core, the thin spread left after the company places raised funds at the bank, was weaker in 2025. The reported result looked steadier mainly because there were NIS 4.307 million of fair-value income on deposits, NIS 2.147 million of other finance income, and expected credit-loss expense fell to only NIS 99 thousand from NIS 403 thousand the year before.

That is the heart of the story. In 2025 the company did not become economically stronger just because net profit held up. The more conservative read is the opposite: the underlying spread weakened, and the reported number looked steadier because of accounting and other supporting items around it.

This is not an operating company, so efficiency is measured differently

Jerusalem Issues has no employees and no fixed assets or facilities of its own. It receives manpower, office, and IT services from Bank Jerusalem, and pays a fixed annual service fee of NIS 75 thousand. G&A expense was only NIS 355 thousand in 2025. So this is not a question of utilization, revenue per employee, or a classic operating-efficiency program. Efficiency here means one thing: can the company still roll debt, place the proceeds at equal or better terms with the bank, and keep a positive residual spread.

On that measure, 2025 was mixed. The company added a new series and expanded the balance sheet. But the fall in the core spread says that larger scale did not translate into better economics for the issuer itself.

The real competition shows up in funding price

The report explicitly says the relevant competitors are other banking groups and their auxiliary corporations, as well as other issuers with similar ratings. In practice, for Jerusalem Issues competition is not about retail market share or product differentiation. It is about the pricing at which Bank Jerusalem can raise through this wrapper relative to other funding alternatives.

That is where the November document set becomes revealing. Ratings were stable, the issue was completed, but pricing cleared at the coupon ceiling and demand was overwhelmingly institutional. In other words, the debt market still opens the door, but not at terms that suggest especially cheap or especially deep demand.

Cash Flow, Debt And Capital Structure

Cash flow: the right frame here is all-in cash

For Jerusalem Issues, the correct cash frame is all-in cash flexibility rather than "free cash flow" in the usual sense. This company passes issuance proceeds into bank deposits, so most cash movement is simply the mirror image of financing activity.

In 2025 operating cash flow was negative NIS 2.265 million, despite NIS 7.455 million of net profit. That is not a typical operating red flag. It mostly reflects interest timing, taxes, and the accounting structure of the issuer. At the same time, investing activity generated NIS 1.888 million net and financing activity generated NIS 6.666 million net, taking cash and cash equivalents up to NIS 72.127 million from NIS 65.838 million. Of that, NIS 68.313 million sat in a short-term deposit at Bank Jerusalem at prime minus 1.90%.

The takeaway is straightforward. The cash balance does not tell a story of wide capital flexibility. It is mainly a thin operating buffer relative to a debt stack of almost NIS 3 billion, with the real anchor still coming from the matched structure versus the bank and the bank's payment commitment to holders.

Debt structure and covenants: this is more about credit trust than covenant pressure

The report says the company met all trust-deed conditions and undertakings during 2025. There is no exposed story here of covenant proximity or classic financial stress. On the regulatory side, the company is not required to meet a standalone minimum-capital ratio because Bank Jerusalem consolidates it, indemnifies its obligations, and maintains unified control over the relevant limits.

That means the central risk is not "will the issuer itself trip a covenant." The real issue is whether the credit market continues to treat this wrapper almost like Bank Jerusalem credit. That is a more important distinction than it may look at first sight.

The equity cushion is still very small

At December 31, 2025 equity stood at only NIS 48.176 million against a NIS 3.03 billion balance sheet. That is a cushion of roughly 1.6% of assets. One can argue that this is normal for a matched-book debt issuer, and the report itself presents market and liquidity exposure as immaterial. But it would be a mistake to skip the number. It is a reminder that any real shock will not be absorbed at this company level. It will go almost directly to the parent layer.

The maturity ladder is spread out, but it is still real

Over the next 12 months the company has NIS 615.3 million of debt securities due within one year, plus another NIS 648.6 million from one to two years. Then come NIS 610.7 million between two and three years, NIS 460.4 million between three and four, NIS 275.5 million between four and five, and NIS 371.5 million beyond five years.

This is not a maturity wall that screams immediate trouble, but it does require a market that stays open and a refinancing machine that keeps working. For an issuer like this, "everything is fine" effectively means the market door remains open almost all the time.

Series mix: Series 16, 18 and 19 remain large, while Series 20 moved into the center quickly

Series 20 already stood at roughly NIS 387.2 million in carrying terms at the report date. It is still smaller than Series 16, 18, and 19, but it is no sideshow. Within one month it became another meaningful funding anchor. That is why the key question for the coming year is not whether the company managed to launch it once, but whether it marks a more stable funding window or only a successful use of a specific market moment.

Outlook

Four findings that need to be on the table before looking forward

• Finding one: 2025 was a year of balance-sheet growth, not a year of better core spread economics.
• Finding two: Series 20 proved market access, but not pricing power.
• Finding three: the real economic risk still sits almost entirely at Bank Jerusalem, not at the debt issuer itself.
• Finding four: part of the debt stack already sits back with the bank, so the market should be careful not to read the full stack as purely external demand.

From here, 2026 looks like a funding bridge year. There is no new product to commercialize and no efficiency program that suddenly changes margins. The test is whether Bank Jerusalem can continue to use this company as a funding vehicle at a reasonable cost, while keeping ratings stable and handling the upcoming maturity ladder.

The datapoint the market may miss on first read is that stable net profit does not mean a stronger core engine. It means the opposite. The core spread weakened, while the reported line looked better because of lower expected credit-loss expense and other finance items. That is why a future issue at better pricing would be a stronger signal than another small earnings print from the company.

What has to happen over the next 2 to 4 quarters for the thesis to strengthen is now fairly clear. First, Bank Jerusalem ratings and outlook need to stay stable. Second, the next funding round, if it comes, should show that pricing is not getting worse than the 2.57% level of Series 20. Third, the company needs to show that the core spread stops eroding even after the balance sheet has already grown. Fourth, bank-held positions in the company's bonds should not keep rising to a level that further muddies the picture of true outside demand.

What could break this interpretation is just as clear: weaker Bank Jerusalem credit quality, tighter market conditions, or any evidence that future debt issues need to clear at a meaningfully higher price. If that happens, Jerusalem Issues will not provide an independent line of defense. It will simply reflect the pressure more quickly.

Risks

This is almost a single-name credit exposure

The report explicitly says the company does not extend credit other than deposits at Bank Jerusalem. That is both the strength and the weakness. On the one hand, there is no broad problem loan book. On the other hand, risk is concentrated almost entirely in one bank. If Bank Jerusalem stays strong, the structure works. If its credit quality weakens, there is no diversification engine here to offset the damage.

The real liquidity risk is market access, not cash on the balance sheet

The company itself defines liquidity risk mainly as a slowdown in the ability to raise tradable or institutional debt because of market conditions, regulation, or changing investor preferences. That is a more important risk than any raw reading of cash on hand. The cash buffer is not supposed to service a nearly NIS 3 billion debt stack. The market needs to stay open, and that is the practical risk.

No dedicated collateral pool, only the bank undertaking

Holder protection here does not come from a ring-fenced pledged asset. It comes from the matched deposit structure versus the bank and from Bank Jerusalem's undertaking to the trustees to meet the payment terms of the debt securities. That can work well, but it again means the real question is bank credit, not the "health" of the subsidiary on a standalone basis.

A steady bottom line can hide real weakening underneath

If someone reads 2025 only through net profit, they may conclude that everything stabilized. That is the dangerous read. Net interest and linkage income weakened sharply, and the basic economics of the issuer did not improve. One of the biggest analytical risks here is therefore not only execution risk by the company. It is a market misread of what the reported earnings line is really saying.

Conclusions

Jerusalem Issues ended 2025 with a bigger balance sheet, a wider debt stack, and another demonstrated point of access to the capital market. That is the part supporting the thesis. What prevents a cleaner read is that the issuer itself remains a very thin debt wrapper: the equity cushion is small, the core spread weakened, and almost all meaningful risk still sits with Bank Jerusalem.

Current thesis in one line: Jerusalem Issues is not a business-expansion story but a Bank Jerusalem funding-access story, and in 2025 scale grew faster than economic quality.

Relative to the earlier understanding of the company, three things changed: a new and meaningful series was added, the balance sheet grew by about 4%, and the near-term maturity stack was spread a bit further along the curve. The strongest counter-thesis is that the weakening of the core spread should not be overread, because this issuer was never designed to earn a large spread in the first place. What really matters is only Bank Jerusalem credit stability and continued access to debt markets.

What could change the market reading in the near to medium term is not another small move in net profit, but the pricing of the next issue, the rating path of Bank Jerusalem, and whether the next round of demand comes from a broader investor base or once again from an almost fully institutional book. Why this matters is that this is how the market will decide whether Bank Jerusalem is truly strengthening its funding access through this vehicle, or only adding volume without improving quality.

What has to happen over the next 2 to 4 quarters is already visible: ratings need to stay stable, the maturity ladder needs to be refinanced without a heavier price, and the core spread needs to stop eroding. What would weaken the read is equally visible: any tightening in market conditions or any deterioration in Bank Jerusalem credit quality.